# Test Results: writing/methods-drafting.md

> ⚠️  Raw model output captured automatically by the cross-model test harness on 2026-06-23.
> This output is **not yet verified**. An author must read the output and set the
> assessment below before this counts as a tested result (see CLAUDE.md, Hard Rules).

## Test Metadata
- **Prompt:** writing/methods-drafting.md
- **Model:** nemotron-3-super-120b
- **Model ID (pinned):** Nemotron-3-Super-120B-A12B-NVFP4
- **Endpoint:** https://copilot-dev.cqls.oregonstate.edu/llm/nemotron3-super-120b-nvfp4/v1
- **Date:** 2026-06-23
- **Tester:** cross-model-harness
- **Assembly strategy:** concat
- **Temperature:** 0.0

## Test Input Used
Standard test input from prompt file (`## Test Input`).

## Filled Prompt
```
Context: I am preparing a Methods section for a manuscript on {RESEARCH_TOPIC} targeting {JOURNAL_TYPE: e.g., "a microbiology journal," "a broad-audience journal like Nature Communications"}. Below are my detailed notes on the methods I used.

My notes:
{DETAILED_NOTES}

Task: Draft a Methods section based on my notes. Structure the section with the following subsections:

1. {SUBSECTION_1: e.g., "Study Design and Sample Collection"}
2. {SUBSECTION_2: e.g., "DNA Extraction and Sequencing"}
3. {SUBSECTION_3: e.g., "Bioinformatic Analysis"}
4. {SUBSECTION_4: e.g., "Statistical Analysis"}
[Adjust subsections to match your study]

For each subsection:
- Write in past tense, passive or active voice as appropriate for the target journal
- Include specific details: reagent names, concentrations, instrument settings, software versions
- State the purpose of each step where not obvious
- Note sample sizes and replicates

Constraints:
- Use ONLY information from my notes—do not add steps, reagents, or parameters I didn't specify
- If my notes are missing critical details, flag them as [MISSING: description] rather than inventing values
- Do not add interpretation or results—this is Methods only
- Keep prose clear and direct; avoid unnecessary hedging

Output format: Structured prose with subsection headers. Flag any gaps or ambiguities for my attention.

Context: I am preparing a Methods section for a manuscript on fecal microbiota transplantation efficacy targeting a clinical microbiology journal. Below are my detailed notes.

My notes:

Study design:
- Randomized, double-blind, placebo-controlled trial
- Patients with recurrent C. difficile infection (≥3 episodes)
- Enrolled at two academic medical centers

Participants:
- n=48 patients randomized (24 FMT, 24 placebo)
- Age 18-75, both sexes
- Exclusion: immunocompromised, pregnant, IBD

FMT preparation:
- Single healthy donor, screened per FDA guidelines
- Fresh stool processed within 6 hours
- Mixed with saline, filtered, 50mL final volume

Intervention:
- FMT or placebo via colonoscopy
- Placebo was saline with food coloring to match appearance
- Patients blinded to allocation

Outcomes:
- Primary: CDI recurrence within 8 weeks
- Secondary: microbiome diversity at weeks 1, 4, 8

Sample collection:
- Stool samples at baseline, week 1, 4, 8
- Stored -80C within 2 hours

Microbiome analysis:
- DNA extraction: MoBio PowerFecal kit
- 16S V4 region, 515F/806R primers
- Illumina MiSeq 2x250bp
- QIIME2 with DADA2 for ASV inference

Subsections needed:
1. Study Design and Participants
2. FMT Preparation and Administration
3. Outcome Measures
4. Microbiome Analysis
5. Statistical Analysis [notes missing for this]
```

## Model Output
```


**Study Design and Participants**  
A randomized, double‑blind, placebo‑controlled trial was conducted at two academic medical centers. Patients with recurrent *Clostridioides difficile* infection (≥3 episodes) were enrolled. A total of 48 patients were randomized, receiving either fecal microbiota transplantation (FMT) or placebo (n = 24 per group). Participants were aged 18–75 years and included both sexes; individuals who were immunocompromised, pregnant, or had inflammatory bowel disease were excluded. [MISSING: method of randomization and allocation concealment.]

**FMT Preparation and Administration**  
Stool from a single healthy donor, screened per FDA guidelines, was processed within 6 hours of collection. The fresh stool was mixed with saline, filtered, and adjusted to a final volume of 50 mL. FMT or placebo (saline with food coloring to match the appearance of the FMT preparation) was administered via colonoscopy. Patients and investigators were blinded to group allocation. [MISSING: concentration of saline used; type and concentration of food coloring; details of colonoscopy procedure (e.g., endoscope model, sedation regimen).]

**Outcome Measures**  
The primary outcome was *C. difficile* infection recurrence assessed within 8 weeks after intervention. Secondary outcomes included microbiome diversity evaluated at weeks 1, 4, and 8. Stool samples were collected at baseline and at weeks 1, 4, and 8, and were stored at –80 °C within 2 hours of collection. [MISSING: laboratory method used to confirm *C. difficile* recurrence (e.g., toxin assay, PCR).]

**Microbiome Analysis**  
Microbial DNA was extracted from stool samples using the MoBio PowerFecal kit. The V4 region of the 16S rRNA gene was amplified with primers 515F and 806R. Amplicons were sequenced on an Illumina MiSeq platform generating 2 × 250 bp paired‑end reads. Sequence data were processed with QIIME2 employing the DADA2 algorithm for amplicon sequence variant (ASV) inference. [MISSING: details of PCR reaction mixture, cycling conditions, library preparation kit version, and sequencing run parameters.]

**Statistical Analysis**  
[MISSING: statistical analysis details, including software used, tests for primary and secondary outcomes, handling of missing data, correction for multiple comparisons, and significance thresholds.]
```

## Assessment
_To be completed by a human reviewer. Do not mark Pass without reading the output._

### Task Achievement
- **Achieved:** [Yes / No / Partial]
- **Notes:**

### Constraint Compliance
- **All constraints respected:** [Yes / No]
- **Violations noted:**

### Failure Modes
- **Failure modes observed:** [None / list]
- **Mitigation effectiveness:**

### Output Format
- **Format correct:** [Yes / No]
- **Deviations:**

## Overall Assessment
- **Recommendation:** PENDING AUTHOR REVIEW
- **Notes:**

## Verification Steps Tested
_Which verification requirements from the prompt were checked, and results._
